➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
McKinsey
Colorcon
Merck
McKesson

Last Updated: May 13, 2021

DrugPatentWatch Database Preview

Novast Labs Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for NOVAST LABS, and what generic and branded alternatives to NOVAST LABS drugs are available?

NOVAST LABS has seventy approved drugs.

There are three tentative approvals on NOVAST LABS drugs.

Summary for Novast Labs
US Patents:0
Tradenames:67
Ingredients:51
NDAs:70

Drugs and US Patents for Novast Labs

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novast Labs NIFEDIPINE nifedipine TABLET, EXTENDED RELEASE;ORAL 202987-002 Aug 25, 2016 AB1 RX No Yes   Get Started for $10   Get Started for $10
Novast Labs HER STYLE levonorgestrel TABLET;ORAL 207976-001 Mar 11, 2016 OTC No No   Get Started for $10   Get Started for $10
Novast Labs QUETIAPINE FUMARATE quetiapine fumarate TABLET, EXTENDED RELEASE;ORAL 208947-001 Nov 29, 2017 AB RX No No   Get Started for $10   Get Started for $10
Novast Labs DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 208783-002 Jun 14, 2019 AB3 RX No No   Get Started for $10   Get Started for $10
Novast Labs SETLAKIN ethinyl estradiol; levonorgestrel TABLET;ORAL 090716-001 Sep 15, 2014 AB RX No No   Get Started for $10   Get Started for $10
Novast Labs PRIMAQUINE PHOSPHATE primaquine phosphate TABLET;ORAL 206043-001 Jun 23, 2016 AB RX No No   Get Started for $10   Get Started for $10
Novast Labs DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 208783-003 Jun 14, 2019 AB3 RX No No   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Mallinckrodt
Johnson and Johnson
Baxter
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.